CXCL16 and systemic sclerosis: CXCL16 was also expressed on dermal ECs, with its expression significantly decreased on proximal (18% ± 4) and distal SSc skin (20% ± 4) compared to normal skin (45% ± 10, P < 0.05, Figure 3B).